Gut microbiome and metabolic responses of adult zebrafish (Danio rerio) to the co-exposure of polyethylene microplastics and levofloxacin
Environmental Pollution · 2026-08 · 402 · 128358
DOI: 10.1016/j.envpol.2026.128358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Pollution, 2026-08. Verfasst von Mingcan Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Civil and Environmental Engineering, National University of Singapore, 117576, Singapore. Hauptthemen laut MEDLINE: Microplastics, Zebrafish, Gastrointestinal Microbiome, Water Pollutants, Chemical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 116 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea, National Research Foundation of Korea, Korea University.
Abstract (Originalsprache)
The co-occurrence of microplastics (MPs) and antibiotics in aquatic environments poses complex ecological risks. This study investigated the combined toxicity of polyethylene microplastics (PE MPs) and levofloxacin (LEV) in zebrafish using integrated untargeted metabolomics and gut microbiome profiling. Zebrafish were exposed to environmentally relevant concentrations of LEV (0.1 μg/L, 1 μg/L, 100 μg/L), PE (1 mg/L), and their combinations for 96 h. LEV exposure produced concentration-dependent metabolic toxicity, progressing from energy conservation at 0.1 μg/L to inflammatory activation at 1 μg/L, and ultimately to system-wide metabolic perturbation at 100 μg/L. PE independently disrupted oxidative stress and membrane integrity pathways. Co-exposure generated emergent interactive effects exceeding additive predictions, with PE + LEV 0.1 μg/L affecting 387 metabolites versus 245 for LEV alone. Crucially, co-exposure elicited synergistic toxicity with unique metabolic fingerprints-including neuroendocrine activation (dynorphin B) and mTOR signaling modulation-that were absent in individual treatments. Conversely, microbiome analysis revealed an antagonistic interaction; while LEV alone caused significant dysbiosis and enrichment of resistant taxa, co-exposure stabilized microbial diversity and composition, likely due to LEV adsorption onto PE particles reducing luminal bioavailability. These findings highlight a "microbiome-host interaction paradox": PE mitigates antibiotic-induced gut dysbiosis yet exacerbates host systemic toxicity through mechanisms of epithelial barrier disruption and pharmacokinetic modulation. This study demonstrates that microbiome stability does not reliably predict host physiological health under multi-stressor conditions, underscores the importance of integrative, multi-omics approaches to assess the emergent risks of complex environmental mixtures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Civil and Environmental Engineering, National University of Singapore, 117576, Singapore.
- Department of Environmental Engineering, Korea University, Sejong Campus, Sejong City, 30019, South Korea. Electronic address: swbae@korea.ac.kr.
Förderung
- Ministry of Science and ICT, South Korea
- National Research Foundation of Korea
- Korea University
Zitieren
APA
Li, M., Liu, T., Yuan, Y., & Bae, S. (2026). Gut microbiome and metabolic responses of adult zebrafish (Danio rerio) to the co-exposure of polyethylene microplastics and levofloxacin. Environmental Pollution, 402, 128358. https://doi.org/10.1016/j.envpol.2026.128358
Vancouver
Li M, Liu T, Yuan Y, Bae S. Gut microbiome and metabolic responses of adult zebrafish (Danio rerio) to the co-exposure of polyethylene microplastics and levofloxacin. Environmental Pollution. 2026;402:128358. doi:10.1016/j.envpol.2026.128358
BibTeX
@article{Li2026,
author = {Li, Mingcan and Liu, Tianqi and Yuan, Yue and Bae, Sungwoo},
title = {Gut microbiome and metabolic responses of adult zebrafish (Danio rerio) to the co-exposure of polyethylene microplastics and levofloxacin},
journal = {Environmental Pollution},
year = {2026},
volume = {402},
pages = {128358},
doi = {10.1016/j.envpol.2026.128358}
}
EUVIMED